In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, gives a snapshot of key stroke prevention trial data that were unveiled in 2020—the THALES trial, the RIVER trial, and the Treat Stroke to Target Trial. A full transcript is provided.
In a randomized study, researchers investigated whether using a stroke alarm clock that demands active feedback from stroke physicians could help accelerate acute stroke care. Neurology Learning Network discussed these findings further with study author Klaus Fassbender, MD.
In part 3 of this podcast series, Dr Sarraj discusses factors that determine whether PFO closure is beneficial for each patient, scores and imaging modalities that can be used to help determine this, and patient expectations following the procedure.
Amrou Sarraj, MD: Evidence for PFO Closure vs Medical Management Alone in Reducing Stroke Recurrence
In part 2 of this podcast series, Dr Sarraj gives an overview of evidence from various clinical trials for the closure of patent foramen ovale (PFO) compared with medical management alone for the prevention of stroke recurrence among patients with PFO.
In this podcast, Dr Parikh discusses the findings of his recent study, which indicated that, smoking rates have not decreased over the past 2 decades among survivors of acute ischemic stroke, unlike the general population. He also reviews pharmacologic and nonpharmacologic interventions that may aid smoking cessation efforts among stroke survivors.
In part 1 of this podcast series, Dr Sarraj discusses the etiology and special characteristics of patients with patent foramen ovale (PFO) and PFO-associated stroke compared with patients with traditional stroke risk factors, as well as how to approach these patients from a neurologist's standpoint in collaboration with cardiologists and general practitioners.
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare beneficiaries aged 65 years or older with acute ischemic stroke.
Hooman Kamel, MD, talks about embolic strokes of undetermined source (ESUS), the current standard of care for diagnosing and treating ESUS, and the evolution of research around ESUS.
In this podcast, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events.
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in order to identify appropriate candidates for endovascular therapy.